Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q17142033> ?p ?o }
Showing triples 1 to 18 of
18
with 100 triples per page.
- Q17142033 subject Q7145140.
- Q17142033 abstract "Lipoglycopeptides are a class of antibiotic that have lipophilic side-chains linked to glycopeptides. The class includes oritavancin, telavancin and dalbavancin.In September 2009 the FDA approved Vibativ (telavancin) for complicated skin and skin structure infections (cSSSI)On May 23, 2014 FDA approved Dalvance (dalbavancin), an injectable drug, administered intravenously in two doses one week apart.On August 6, 2014 FDA approved Orbactiv (oritavancin), an injectable drug administered as a single dose to comprise a full course of therapy.Telavancin is the most potent of the 3 against Clostridium spp.".
- Q17142033 wikiPageWikiLink Q12187.
- Q17142033 wikiPageWikiLink Q131271.
- Q17142033 wikiPageWikiLink Q188121.
- Q17142033 wikiPageWikiLink Q204711.
- Q17142033 wikiPageWikiLink Q2425020.
- Q17142033 wikiPageWikiLink Q327663.
- Q17142033 wikiPageWikiLink Q5210237.
- Q17142033 wikiPageWikiLink Q5465429.
- Q17142033 wikiPageWikiLink Q595158.
- Q17142033 wikiPageWikiLink Q7102878.
- Q17142033 wikiPageWikiLink Q7145140.
- Q17142033 wikiPageWikiLink Q7535374.
- Q17142033 wikiPageWikiLink Q7695658.
- Q17142033 wikiPageWikiLink Q898401.
- Q17142033 comment "Lipoglycopeptides are a class of antibiotic that have lipophilic side-chains linked to glycopeptides.".
- Q17142033 label "Lipoglycopeptide".